CORE LABORATORIES INC.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $29.7M | $31.4M | $36.7M | $19.5M | $19.7M |
| Depreciation & Amortization | $14.6M | $15.0M | $15.8M | $17.2M | $18.5M |
| Depreciation | $14.3M | $14.4M | $15.3M | $16.5M | $17.8M |
| Amortization | $359.0K | $504.0K | $490.0K | $685.0K | $762.0K |
| Stock-Based Compensation | $7.1M | $3.8M | $14.0M | $7.8M | $19.1M |
| Net Cash from Operating Activities | $37.0M | $56.4M | $24.8M | $25.0M | $36.6M |
| Investing Activities | |||||
| Capital Expenditures | $11.2M | $11.9M | $10.6M | $10.2M | $13.5M |
| Business Acquisitions | $1.2M | $0 | $0 | — | — |
| Net Cash from Investing Activities | $-2.2M | $-6.4M | $-6.7M | $-3.9M | $-10.2M |
| Financing Activities | |||||
| Dividends Paid | $1.9M | $1.9M | $1.9M | $1.9M | $1.8M |
| Stock Repurchases | $12.4M | $5.3M | $2.2M | $3.9M | $8.3M |
| Net Cash from Financing Activities | $-31.3M | $-46.0M | $-18.4M | $-23.4M | $-22.5M |
| Net Change in Cash | — | — | — | — | — |
| Free Cash Flow | $25.8M | $44.5M | $14.2M | $14.7M | $23.0M |